Company Profile
Veeva Stock Price, News & Catalysts
- Ticker:
- VEEV
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
281.93 USD (-1.23%)
Close
Last updated: October 1, 2026
29.9B USD
Market cap
Why the stock is moving
As of Oct 1, 2026, VEEV closed down 1.23% at $281.93. No new same-company headline was identified in the current news window.
Company overview
Life Sciences Industry Cloud Company
Veeva Systems provides cloud applications, data products, artificial intelligence agents, and consulting services purpose-built for life sciences. Its customers range from emerging biotechnology companies to the world's largest pharmaceutical manufacturers.
Commercial Cloud
Veeva Commercial Cloud includes Vault CRM, content, data, analytics, and customer-engagement applications used by sales, marketing, and medical teams. The suite supports regulated interactions with healthcare professionals and coordinated product commercialization.
Development and Quality Cloud
Development Cloud and Quality Cloud support clinical operations, regulatory information, safety, quality management, training, and manufacturing documentation. These applications create a connected foundation for managing regulated content and processes across the product lifecycle.
Data and Consulting Services
Veeva combines software with reference data, patient and prescriber data products, and consulting. This integrated model helps customers implement common data standards and execute commercial and development programs on the same industry-specific platform.
AI Agents and Falcon Platform
Veeva is embedding standard and configurable agents into Vault applications while developing Falcon as an agentic labor platform for clinical, regulatory, and safety work. The strategy applies AI within governed life-sciences workflows rather than offering a general-purpose horizontal tool.
Future catalysts
- Initial customer go-lives for the Veeva Falcon agentic labor platform by year-end 2026.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Veeva (VEEV)?
Veeva (VEEV) most recently closed at 281.93 USD, a -1.23% move versus the previous session.
What is the market cap of Veeva (VEEV)?
Veeva currently has a market capitalization of 29.9B USD on BioPharmSignal.
What does Veeva do?
Life Sciences Industry Cloud Company Veeva Systems provides cloud applications, data products, artificial intelligence agents, and consulting services purpose-built for life sciences. Its customers range from emerging biotechnology companies to the world's largest pharmaceutical manufacturers. Commercial Cloud Veeva Commercial Cloud includes Vault CRM,...
On which exchange is VEEV stock listed?
Veeva (VEEV) is associated with NYSE, United States, Biopharma.
What is Life?
Life Sciences Industry Cloud Company Veeva Systems provides cloud applications, data products, artificial intelligence agents, and consulting services purpose-built for life sciences.
Which conditions is Veeva targeting with Life?
Life Sciences Industry Cloud Company Veeva Systems provides cloud applications, data products, artificial intelligence agents, and consulting services purpose-built for life sciences. Its customers range from emerging biotechnology companies to the world's largest pharmaceutical manufacturers. Commercial Cloud Veeva Commercial Cloud includes Vault CRM,...
How does Veeva describe recent progress with Life?
Initial customer go-lives for the Veeva Falcon agentic labor platform by year-end 2026.
What is Sciences?
Life Sciences Industry Cloud Company Veeva Systems provides cloud applications, data products, artificial intelligence agents, and consulting services purpose-built for life sciences.